Short-term application of low-dose growth hormone in surgical patients: Effects on nitrogen balance and blood glucose

Table 3 Nutritional condition measurement of two group patients

Test	D 1	D 3	D 10
Albumin (g/L)
rhGH	40.85 ± 3.09	33.26 ± 3.82	35.16 ± 4.21
Placebo	41.19 ± 4.17	33.95 ± 3.68	35.57 ± 3.84
Transferrin (g/L)
rhGH	2.41 ± 0.45	1.75 ± 0.44	2.15 ± 0.66
Placebo	2.51 ± 0.45	1.79 ± 0.42	2.11 ± 0.44
Prealbumin (mg/L)
rhGH	133.90 ± 83.95	71.44 ± 46.54	105.51 ± 69.30
Placebo	164.03 ± 88.16	85.55 ± 57.87	109.99 ± 97.37
Fibronectin (mg/L)
rhGH	97.40 ± 11.74	80.85 ± 8.13	104.77 ± 19.94a
Placebo	98.70 ± 20.17	83.69 ± 10.50	93.03 ± 16.03
TLC (109/L)
rhGH	1.64 ± 0.60	1.03 ± 0.33	1.36 ± 0.54
Placebo	1.59 ± 0.52	1.15 ± 0.59	1.38 ± 0.46

Values are mean ± SD. TLC: Total lymphocyte count.

^aP < 0.05 vs placebo group.